PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer’s Disease

Presenilin-2 (PSEN2) mutation Thr421Met was identified from a 57-years old patient with early onset Alzheimer’s disease (EOAD) for the first time in Korea. Previously, this mutation was discovered in an EOAD patient in Japan without a change on amyloid production from the cellular study. Both Korean...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, YoungSoon, Bagyinszky, Eva, An, Seong Soo A., Kim, SangYun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656741/
https://www.ncbi.nlm.nih.gov/pubmed/36362122
http://dx.doi.org/10.3390/ijms232113331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656741/
https://www.ncbi.nlm.nih.gov/pubmed/36362122
http://dx.doi.org/10.3390/ijms232113331

Ejemplares similares